Shares in Novo Nordisk rose on Monday, after it got U.S. approval for its weight-loss drug Wegovy to treat a serious liver ...

The upcoming meeting between Ukraine's President Volodymyr Zelenskiy and US President Donald Trump together with European ...

The FTSE 100 and European markets were mixed in early trade on Monday as Ukrainian president Volodymyr Zelensky and a handful ...

HSBC Chief Multi-Asset Strategist Max Kettner says high-frequency data coming out of the US points to a better earnings ...

Anna Edwards, Guy Johnson, Kriti Gupta and Mark Cudmore break down today's key themes for analysts and investors on ...

If there is one thing that is clear three months out from the Autumn Budget, it is that Chancellor Rachel Reeves will hike ...

Tesla's reduced production of its Cybertruck is having a ripple effect on owners, some of whom say insurance companies are ...

Asian shares were mostly higher Monday after the S&P 500 and Nasdaq composite edged back from their record levels while the ...

"It was extremely difficult," IgniteTech CEO Eric Vaughan tells Fortune. "But changing minds was harder than adding skills." ...

The fatal explosion last week at U.S. Steel's Pittsburgh-area coal-processing plant has revived debate about its future just ...

The Centers for Medicare & Medicaid Services recently announced a new program to test prior authorization in original ...

In a surprising reversal of the United States’ years-long technology restrictions on China, President Donald Trump last month ...